pre-seed
Stage
2
Investors
About
PharmEnable is a drug discovery company that uses medicinal chemistry and AI computational approaches to design next-generation small molecule drugs, focusing on oncology and neurology.
Explore PharmEnable's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.